An Improved Tat/Rev Induced Limiting Dilution Assay With Enhanced Sensitivity and Breadth of Detection

Front Immunol. 2021 Aug 5:12:715644. doi: 10.3389/fimmu.2021.715644. eCollection 2021.

Abstract

Tat/Rev Induced Limiting Dilution Assay (TILDA) is instrumental in estimating the size of latent reservoirs of HIV-1. Here, we report an optimized TILDA containing a broader detection range compared to the reported methods and high sensitivity. Giving priority to sequence conservation, we positioned the two forward primers and the probe in exon-1 of HIV-1. The reverse primers are positioned in highly conserved regions of exon-7. The optimized TILDA detected eight molecular clones belonging to five major genetic subtypes of HIV-1 with a comparable detection sensitivity. Using the optimized assay, we show that only a minor proportion of CD4+ T cells of primary clinical samples can spontaneously generate multiply spliced viral transcripts. A significantly larger proportion of the cells produced viral transcripts following activation. The optimized TILDA is suitable to characterize HIV-1 latent reservoirs and the therapeutic strategies intended to target the reservoir size.

Keywords: HIV latency; HIV-1; TILDA; latent reservoir; transcriptional silence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Conserved Sequence
  • Genetic Variation
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV-1 / physiology*
  • Humans
  • Nucleic Acid Amplification Techniques* / methods
  • Nucleic Acid Amplification Techniques* / standards
  • Polymerase Chain Reaction
  • RNA, Viral
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Viral Load*
  • Virus Latency*
  • rev Gene Products, Human Immunodeficiency Virus / chemistry
  • rev Gene Products, Human Immunodeficiency Virus / genetics*
  • tat Gene Products, Human Immunodeficiency Virus / chemistry
  • tat Gene Products, Human Immunodeficiency Virus / genetics*

Substances

  • RNA, Viral
  • rev Gene Products, Human Immunodeficiency Virus
  • rev protein, Human Immunodeficiency Virus-1
  • tat Gene Products, Human Immunodeficiency Virus